
US government plans to purchase large supply of COVID-19 treatment sotrovimab for winter surge
Fox News
The United States government announced plans to purchase sotrovimab, an investigational monoclonal antibody used for the early treatment of COVID-19
Sotrovimab was granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) in May 2021. Under the EUA, the investigational single-dose intravenous infusion SARS-CoV-2 monoclonal antibody can be used to treat mild-to-moderate COVID-19 in adults and children 12 years of age and older, who tested positive for COVID-19, and are at high risk for developing severe cases of COVID-19 leading to hospitalization or death, according to the FDA website.
"It gives patients a real heads start in fighting off the virus," Bart Murray, Vice President of COVID Therapeutics at GSK told Fox news in an interview.

College student dies in tragic ski accident at Wisconsin resort, marking second death within a month
Ski accident kills Alexandra Blattner, 20-year-old University of Wisconsin-Oshkosh student, who reportedly crashed into a tree at Granite Peak Ski Resort on Feb. 5.












